What is the recommended perioperative management of bronchospasm?

Management of Perioperative Bronchospasm

Immediately administer inhaled short-acting beta-2 agonists (albuterol 2.5 mg nebulized or 2-3 puffs via MDI) as first-line therapy, while simultaneously deepening anesthesia with sevoflurane and administering intravenous agents including ketamine (0.5-1 mg/kg), magnesium sulfate (2 g IV), and dexmedetomidine to achieve rapid bronchodilation through a multimodal approach 1, 2.

Immediate Intraoperative Management Algorithm

When bronchospasm occurs during surgery, time is critical to prevent dynamic hyperinflation syndrome and cardiovascular collapse 1. The following sequence should be executed rapidly:

First-Line Actions (0-2 minutes):

• Increase FiO2 to 100% and deepen anesthesia immediately
• Administer inhaled beta-2 agonists: Albuterol 2.5 mg in 3 cc saline via nebulizer for adults (can double dose for severe cases), or 2-3 puffs via MDI with spacer 3
• Switch to or deepen sevoflurane - this volatile anesthetic has direct bronchodilatory effects 1, 4
• Remove triggering stimuli: Stop surgical stimulation if possible, ensure adequate depth of anesthesia

Second-Line Agents (2-5 minutes if inadequate response):

• Ketamine 0.5-1 mg/kg IV - provides bronchodilation through multiple mechanisms 1
• Magnesium sulfate 2 g IV over 20 minutes - smooth muscle relaxant 1
• Lidocaine 1-1.5 mg/kg IV - blunts airway reflexes 1
• Ipratropium bromide 0.5 mg nebulized - adds anticholinergic bronchodilation, particularly effective for beta-blocker-induced bronchospasm 3

Third-Line (Refractory Cases):

• Dexmedetomidine bolus and infusion - reduces airway reactivity 1
• Systemic corticosteroids: Methylprednisolone 40-60 mg IV or 1-2 mg/kg in children (maximum 60 mg) 3
• Epinephrine for life-threatening bronchospasm: 10-20 mcg IV boluses titrated to effect

Critical Ventilation Strategy

Avoid aggressive ventilation - this is a common pitfall that worsens outcomes 1, 2:

• Reduce respiratory rate to allow prolonged expiratory time (I:E ratio of 1:3 or 1:4)
• Decrease tidal volumes to 4-6 mL/kg to prevent barotrauma
• Accept permissive hypercapnia unless contraindicated
• Monitor peak inspiratory pressures closely - rising pressures indicate worsening bronchospasm or dynamic hyperinflation

Key Evidence Considerations

The contemporary literature strongly advocates for multimodal therapy rather than relying solely on beta-2 agonists 1. While the EPR-3 guidelines 3 provide dosing for albuterol and ipratropium as standard bronchodilators, these older guidelines (2007) do not address the full armamentarium of intravenous agents now recognized as highly effective for perioperative bronchospasm.

The 2020 review by Woods et al. 1 emphasizes that intravenous agents like ketamine, magnesium, lidocaine, and dexmedetomidine are currently underutilized despite strong evidence for their efficacy. These agents work through different mechanisms than beta-2 agonists and provide additive benefit.

Preoperative Risk Mitigation

To prevent intraoperative bronchospasm 2, 5, 4:

• Continue all maintenance asthma medications through the morning of surgery, including inhaled corticosteroids
• Optimize asthma control preoperatively - postpone elective surgery if patient has had recent exacerbations, active upper respiratory infection, or poor control
• Administer preoperative albuterol 15-30 minutes before induction in high-risk patients
• Consider preoperative systemic corticosteroids (prednisone 40-60 mg or equivalent) for patients with recent exacerbations or poorly controlled asthma 3

Anesthetic Technique Selection

Prefer volatile anesthetics (sevoflurane) over propofol-based TIVA for maintenance, as volatiles have direct bronchodilatory effects 4, 6. For induction:

• Propofol is acceptable and may reduce airway reactivity compared to other induction agents
• Avoid histamine-releasing agents (morphine, atracurium, mivacurium)
• Ensure adequate depth before airway manipulation - light anesthesia is a major trigger
• Consider avoiding intubation when feasible - use supraglottic airways or mask ventilation for appropriate cases

Common Pitfalls to Avoid

1. Relying solely on albuterol - this monotherapy approach often fails in severe bronchospasm 1
2. Aggressive ventilation - high respiratory rates and tidal volumes cause air trapping and hemodynamic collapse 1, 2
3. Delayed steroid administration - steroids take 4-6 hours to work, so give early in severe cases 3
4. Misdiagnosis - ensure you're treating true bronchospasm and not endotracheal tube obstruction, pneumothorax, pulmonary edema, or aspiration 2
5. Premature extubation - ensure complete resolution before emergence to avoid rebound bronchospasm

Differential Diagnosis Considerations

When wheezing occurs intraoperatively, rapidly exclude 2:

• Endotracheal tube malposition or obstruction (check with suction catheter)
• Pneumothorax (unilateral breath sounds, sudden desaturation)
• Pulmonary aspiration
• Anaphylaxis (hypotension, rash, angioedema)
• Pulmonary edema (pink frothy secretions)

The combination of bilateral expiratory wheezing, rising peak pressures, prolonged expiratory phase, and difficulty ventilating confirms bronchospasm.